0001073397-21-000003.txt : 20210416
0001073397-21-000003.hdr.sgml : 20210416
20210416195906
ACCESSION NUMBER: 0001073397-21-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210415
FILED AS OF DATE: 20210416
DATE AS OF CHANGE: 20210416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOPEZ GEORGE A
CENTRAL INDEX KEY: 0001073397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 21832778
MAIL ADDRESS:
STREET 1: C/O ICU MEDICAL
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-04-15
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001073397
LOPEZ GEORGE A
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
1
0
1
0
Common Stock
2021-04-15
4
S
0
630
206.7094
D
936213
I
by Partnership
Common Stock
2021-04-15
4
S
0
8412
207.6788
D
927801
I
by Partnership
Common Stock
2021-04-15
4
S
0
5658
208.6166
D
922143
I
by Partnership
Common Stock
2021-04-15
4
S
0
200
209.31
D
921943
I
by Partnership
Common Stock
2021-04-16
4
S
0
1454
207.6511
D
920489
I
by Partnership
Common Stock
2021-04-16
4
S
0
977
208.7857
D
919512
I
by Partnership
Common Stock
2021-04-16
4
S
0
2597
210.0092
D
916915
I
by Partnership
Common Stock
2021-04-16
4
S
0
1608
211.0294
D
915307
I
by Partnership
Common Stock
2021-04-16
4
S
0
1905
211.81
D
913402
I
by Partnership
Common Stock
2021-04-16
4
S
0
1559
212.7818
D
911843
I
by Partnership
Common Stock
240314
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $206.15 to 207.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $207.22 to 208.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $208.23 to 209.11, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
All shares sold were sold at the exact price disclosed.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $207.13 to 207.93, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $208.28 to 209.19, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $209.43 to 210.37, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $210.44 to 211.39, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $211.45 to 212.44, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $212.52 to 213.17, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
By: Paula Darbyshire, Attorney-in-fact For: George A. Lopez, M.D.
2021-04-16